These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15923907)

  • 21. Drug treatment of dyslipidemias: practical guidelines for the primary care physician.
    Bays HE; Dujovne CA; Lansing AM
    Heart Dis Stroke; 1992; 1(6):357-65. PubMed ID: 1344132
    [No Abstract]   [Full Text] [Related]  

  • 22. Lipids in type 2 diabetes.
    Laakso M
    Semin Vasc Med; 2002 Feb; 2(1):59-66. PubMed ID: 16222596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia.
    Svilaas A; Strandberg T; Eriksson M; Hildebrandt P; Westheim A
    Scand Cardiovasc J; 2008 Aug; 42(4):279-87. PubMed ID: 18609053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gemfibrozil for hyperlipidemia.
    Med Lett Drugs Ther; 1982 Jun; 24(612):59-60. PubMed ID: 6953310
    [No Abstract]   [Full Text] [Related]  

  • 25. [Kidney diseases associated with hyperlipidemia and its treatment].
    Aitio ML
    Duodecim; 1991; 107(16):1315-22. PubMed ID: 1365353
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of hyperlipidemia: an update.
    Keller KB; Lemberg L
    Heart Lung; 1990 May; 19(3):317-20. PubMed ID: 2341269
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hypolipemic effects of 1-10(hydroxy-2 ethylthio) decane (LL1558), based on 77 cases of essential hyperlipidemia].
    Rouffy J; Loeper J
    Therapie; 1972; 27(3):433-44. PubMed ID: 4570211
    [No Abstract]   [Full Text] [Related]  

  • 28. [Lipid anomalies during renal insufficiency: consequences on the progression of renal insufficiency and cardiovascular risk].
    Moulin B
    Nephrologie; 2000; 21(7):339-41. PubMed ID: 11200605
    [No Abstract]   [Full Text] [Related]  

  • 29. Managing dyslipidaemia: current concepts.
    Schachter M
    Practitioner; 2002 Jul; 246(1636):496-9. PubMed ID: 12132267
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyperlipidaemia and cardiovascular disease.
    Roberts AW; Thomas AW
    Curr Opin Lipidol; 2006 Jun; 17(3):366-8. PubMed ID: 16680042
    [No Abstract]   [Full Text] [Related]  

  • 31. [Underutilization of cardiovascular pharmacotherapy: how to pay for it?].
    Wehling M
    Dtsch Med Wochenschr; 2004 Feb; 129(7):330. PubMed ID: 14765334
    [No Abstract]   [Full Text] [Related]  

  • 32. [Primary prevention of cardiovascular diseases by lowering lipids].
    Klose G
    Internist (Berl); 1997 Jun; 38(6):615-6. PubMed ID: 9265009
    [No Abstract]   [Full Text] [Related]  

  • 33. A scheme for the treatment of hyperlipidemia.
    Spencer JM; Hutchinson RG; Hill JE
    J Miss State Med Assoc; 1990 Apr; 31(4):111-6. PubMed ID: 2332888
    [No Abstract]   [Full Text] [Related]  

  • 34. Orlistat and sibutramine beyond weight loss.
    Mannucci E; Dicembrini I; Rotella F; Rotella CM
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):342-8. PubMed ID: 17928208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of hyperlipidemia in diabetes.
    Vinik AI; O'Brian JT; Georges LP; Leichter SB; Janin Y
    Compr Ther; 1995 Oct; 21(10):602-9. PubMed ID: 8565431
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diabetic dyslipidemia: which target levels and treatment options exist for diabetics?].
    Broedl UC; Lehrke M; Parhofer KG
    MMW Fortschr Med; 2008 Jun; 150(25):41-3. PubMed ID: 18705054
    [No Abstract]   [Full Text] [Related]  

  • 37. [Relationship between cardiovascular diseases and hyperlipemia. Benefits of hypolipemic therapy].
    Daubresse JC; Luyckx A
    Brux Med; 1977 Nov; 57(11):491-7. PubMed ID: 336160
    [No Abstract]   [Full Text] [Related]  

  • 38. Complications and side effects. Crestor tested in PHAs.
    TreatmentUpdate; 2005; 17(4):6-7. PubMed ID: 17230630
    [No Abstract]   [Full Text] [Related]  

  • 39. Lipid management in the geriatric patient.
    Nair AP; Darrow B
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):185-206. PubMed ID: 19217519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of hyperlipidemia with a new drug, tibric acid].
    Carmena R; González R Florez J; Sanchis J
    Rev Clin Esp; 1976 Jul; 142(2):151-5. PubMed ID: 788065
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.